Sanofi, Glaxo advance talks to supply up to 300 million COVID-19 vaccine doses to Europe - companies

FILE PHOTO: The logo of Sanofi is seen at the company's headquarters in Paris, France, April 24, 2020. REUTERS/Charles Platiau/File Photo

(Reuters) - Sanofi SA and GlaxoSmithKline Plc on Friday said they are in advanced discussions with the European Commission to supply up to 300 million doses of the drugmakers's experimental COVID-19 vaccine.

The doses would be manufactured in European countries including France, Belgium, Germany and Italy.

Limited time offer:
Just RM5 per month.

Monthly Plan

~~RM13.90/month~~
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only

Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.

Found a mistake in this article?

Report it to us.

What is the issue about?

Spelling and grammatical error

Factually incorrect

Story is irrelevant

Email (optional)

Sanofi, Glaxo advance talks to supply up to 300 million COVID-19 vaccine doses to Europe - companies

Limited time offer:
Just RM5 per month.

Monthly Plan

Annual Plan

1 month

Found a mistake in this article?

HIGH STANDARDS FOR SEEK PEOPLE & PURPOSE AWARDS

Next In World

Air Pollutant Index

Highest API Readings

Others Also Read

Thank you for downloading.

Sanofi, Glaxo advance talks to supply up to 300 million COVID-19 vaccine doses to Europe - companies

Limited time offer: Just RM5 per month.

Monthly Plan

Annual Plan

1 month

Found a mistake in this article?

HIGH STANDARDS FOR SEEK PEOPLE & PURPOSE AWARDS

Next In World

Trending in News

Air Pollutant Index

Highest API Readings

Select State and Location to view the latest API reading

Others Also Read

Thank you for downloading.

Limited time offer:
Just RM5 per month.